DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease

MANUFACTURER: Theravance Biopharma

USAGE: Oral

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Yupelri (revefenacin) is a medication approved by the Food and Drug Administration (FDA) for the treatment of patients with COPD. It improves lung function by increasing forced expiratory volume in 1 second (FEV1) and reducing symptoms such as coughing and shortness of breath.